217 related articles for article (PubMed ID: 20861792)
1. Fluorescent In-situ Hybridization Study of Non-papillary Oncocytic/Eosinophilic Renal Cell Carcinoma.
Mai KT; Ahmed I; Levac J; Nguyen BN
Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):82-91. PubMed ID: 20861792
[TBL] [Abstract][Full Text] [Related]
2. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma with mixed features of papillary and clear cell cytomorphology: a fluorescent in situ hybridization study.
Mai KT; Faraji H; Desantis D; Robertson SJ; Belanger EC; Levac J
Virchows Arch; 2010 Jan; 456(1):77-84. PubMed ID: 20033232
[TBL] [Abstract][Full Text] [Related]
4. A case of oncocytic papillary renal cell carcinoma.
Okada A; Sasaki S; Fujiyoshi Y; Niimi K; Kurokawa S; Umemoto Y; Kohri K
Int J Urol; 2009 Sep; 16(9):765-7. PubMed ID: 19769658
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence in situ hybridization as an adjunct tool in the diagnosis of primary and metastatic renal cell carcinoma in fine needle aspiration specimens.
Kos Z; Williams PA; Belanger EC; Mai KT
Diagn Cytopathol; 2014 Dec; 42(12):1013-23. PubMed ID: 24692327
[TBL] [Abstract][Full Text] [Related]
6. Oncocytic papillary renal cell carcinoma with solid architecture: mimic of renal oncocytoma.
Mai KT; Kohler DM; Robertson SJ; Belanger EC; Marginean EC
Pathol Int; 2008 Mar; 58(3):164-8. PubMed ID: 18251779
[TBL] [Abstract][Full Text] [Related]
7. Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases.
Skenderi F; Ulamec M; Vanecek T; Martinek P; Alaghehbandan R; Foix MP; Babankova I; Montiel DP; Alvarado-Cabrero I; Svajdler M; Dubinský P; Cempirkova D; Pavlovsky M; Vranic S; Daum O; Ondic O; Pivovarcikova K; Michalova K; Hora M; Rotterova P; Stehlikova A; Dusek M; Michal M; Hes O
Ann Diagn Pathol; 2017 Apr; 27():48-56. PubMed ID: 28325361
[TBL] [Abstract][Full Text] [Related]
8. Imprint cytologic features of chromophobe renal cell carcinoma morphologically resembling renal oncocytoma: is this an oncocytic variant of chromophobe renal cell carcinoma?
Yamaguchi T; Kuroda N; Imamura Y; Hes O; Michal M; Sima R; Nakayama K; Sato N
Diagn Cytopathol; 2010 Jul; 38(7):509-13. PubMed ID: 19941365
[TBL] [Abstract][Full Text] [Related]
9. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
[TBL] [Abstract][Full Text] [Related]
10. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
[TBL] [Abstract][Full Text] [Related]
11. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features.
Kunju LP; Wojno K; Wolf JS; Cheng L; Shah RB
Hum Pathol; 2008 Jan; 39(1):96-101. PubMed ID: 17949780
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic approach to eosinophilic renal neoplasms.
Kryvenko ON; Jorda M; Argani P; Epstein JI
Arch Pathol Lab Med; 2014 Nov; 138(11):1531-41. PubMed ID: 25357116
[TBL] [Abstract][Full Text] [Related]
13. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases.
Hes O; Brunelli M; Michal M; Cossu Rocca P; Hora M; Chilosi M; Mina M; Boudova L; Menestrina F; Martignoni G
Ann Diagn Pathol; 2006 Jun; 10(3):133-9. PubMed ID: 16730306
[TBL] [Abstract][Full Text] [Related]
14. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
[TBL] [Abstract][Full Text] [Related]
15. A collision tumor of papillary renal cell carcinoma and oncocytoma: case report and literature review.
Goyal R; Parwani AV; Gellert L; Hameed O; Giannico GA
Am J Clin Pathol; 2015 Nov; 144(5):811-6. PubMed ID: 26486747
[TBL] [Abstract][Full Text] [Related]
16. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
17. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
18. Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features.
Xia QY; Rao Q; Shen Q; Shi SS; Li L; Liu B; Zhang J; Wang YF; Shi QL; Wang JD; Ma HH; Lu ZF; Yu B; Zhang RS; Zhou XJ
Int J Clin Exp Pathol; 2013; 6(7):1392-9. PubMed ID: 23826421
[TBL] [Abstract][Full Text] [Related]
19. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases.
Han G; Yu W; Chu J; Liu Y; Jiang Y; Li Y; Zhang W
Pathol Res Pract; 2017 Jan; 213(1):1-6. PubMed ID: 27931799
[TBL] [Abstract][Full Text] [Related]
20. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]